Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar ThePoulTrend (49.90) Submitted: 11/11/2011 12:46:54 AM : Outperform Start Price: $34.56 MRK Score: -0.54

Love the Dividend, and Long term Growth

Featured Broker Partners


Advertisement